20-Minute Screening Evaluates Cognitive Impairment Due To Schizophrenia
News | October 23, 2017
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
A 20-minute cognitive screening test is being developed for outpatient settings intended for people diagnosed with schizophrenia is able to assess the person’s degree of cognitive impairment and functional ability in terms of short-term memory, mental agility, and organizational ability. The test is called Epidemiological Study of Cognitive Impairment in Schizophrenia (EPICOG-SCH); it is based…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.